BSM heads into its Q2 2026 print with a clear insider conviction signal stacked against a market that has only recently started to agree.
The most striking data point ahead of today's release is the cluster of insider buying that materialized in May and early June. Executive Chairman Thomas Carter accumulated more than 68,000 units across four sessions in May, spending roughly $924,000. Independent Director D Mark Dewalch added approximately 110,000 units across three consecutive sessions between May 28 and June 1, committing close to $1.5 million at prices in the $13.20–$13.62 range. Net insider buying over the past 90 days totals about 250,000 shares, worth $3.4 million — meaningful for a partnership of this size. The units now trade at $15.05, roughly 10–14% above those purchase prices, so the buyers are already sitting on gains heading into the print.
Options positioning adds a separate layer to the story — and it tilts bullish rather than defensive. The put/call ratio has dropped sharply to 0.45, sitting roughly 1.1 standard deviations below its 20-day average of 0.60. That means call activity is running well ahead of puts right now, the most bullish options tilt in recent weeks. The shift is notable because the PCR was running near its 52-week high of 0.89 just two weeks ago — the rotation toward calls has been fast and pronounced as the stock climbed 9% over the past month. Short interest is not the story here: at under 2% of the free float and falling steadily through July, there is no meaningful short pressure on either side. Borrow availability is loose at 426%, reinforcing that bears have not been loading up.
The analyst picture is thin but consistent with cautious optimism. Coverage is sparse — three hold ratings, one price target from RBC Capital at $16 following an initiation in late May. The current price of $15.05 trades inside that target, leaving only modest implied upside on the Street's numbers. Piper Sandler has tracked the stock for years with a Neutral rating, and while that data predates the six-month freshness threshold, the direction of travel in 2026 has been upward — the firm raised its target to $14 in March 2026 after a series of cuts. Valuation multiples that are available suggest the market is pricing BSM at a P/E around 9x, while the stock's dividend score ranks in the 62nd percentile — not exceptional, but relevant for a minerals partnership whose income profile is the main investment case. The short score has also eased from 57 in mid-July to 53 now, reflecting the steady unwind in short positioning over the past two weeks.
Today's print tests whether the earnings power at current commodity prices justifies both the insider purchases made near $13 and the options market's pivot toward calls at $15.
See the live data behind this article on ORTEX.
Open BSM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
